Blue-green algal virus protein N mutant, modified derivative and application thereof

A technology of cyanobacteria virus and mutants, applied in the field of cyanobacteria virus protein N mutants, can solve the problems of loss of anti-HIV activity and low activity, and achieve the effect of enhanced antiviral activity

Inactive Publication Date: 2010-02-03
JINAN UNIVERSITY
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the anti-HIV activity of CVN (Q62C) is lower than that of unmutated CVN, and since the selected modification site is inside CVN, the body modified by mPEG-maleimide 30KDa (mPEG-MAL-30KDa) Variant nearly loses activity against HIV

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Blue-green algal virus protein N mutant, modified derivative and application thereof
  • Blue-green algal virus protein N mutant, modified derivative and application thereof
  • Blue-green algal virus protein N mutant, modified derivative and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0053] 1. Construction of recombinant plasmid pET3c-6His-SUMO-LCVN

[0054] The construction and synthesis of the SUMO-L-CVN gene is carried out in two steps. First, the L-CVN gene is synthesized by two PCRs. The first PCR uses the pET3c-SUMO-CVN plasmid as a template, and F1-CVN and R-CVN as upstream and downstream primers. The reaction system was 1 ng template, 1 μM upstream and downstream primers, 20 μl Taq PCR MasterMix, added water to 40 μl, the reaction mixture was denatured at 94 °C for 1 min, annealed to 55 °C, maintained for 1 min, extended at 72 °C for 1 min, and performed 29 cycles. The reaction product was subjected to 1% agarose gel electrophoresis, and the target fragment was recovered from the gel, which was used as a template for the next round of PCR. In the second PCR, the PCR product of the previous round was used as a template, and F2-CVN and R-CVN were used as upstream and downstream primer pairs (the F2-CVN primer contained a flexible polypeptide encodin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biological medicines, in particular to a blue-green algal virus protein N mutant, a PEG modified derivative and application thereof. The blue-green algal virus protein N mutant comprises two sequences, one is connecting peptide with hydrophilic flexibility, and the other is a blue-green algal virus protein N sequence optimized by trinucleotide. The derivativeis obtained by PEG modification of the blue-green algal virus protein N mutant; the mutant and the derivative thereof show favorable anti-HIV activity. The invention is applied to preparing anti-HIV or other virus microorganisms.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a cyanobacteria viral protein N (CVN) mutant, its PEG-modified derivative and their application in pharmacy. Background technique [0002] Cyanovirin-N (CVN) is a protein with anti-HIV activity that can be extracted from cyanobacteria by American scientists BOYD et al. CVN can specifically bind to the capsid protein gp120 of human immunodeficiency virus HIV-1 with high affinity to exert antiviral activity. Broad spectrum and stable properties make CVN protein a valuable antiviral drug [BOYD M R, GUSTAFSON K R, MCMAHON J B, et al. protein that binds viral surface envelope glycoprotein gp 120: Potential applications to microbicide development [J]. Antimicrobial Agents and Chemotherapy, 1997, 41(7): 1521-30.]. However, because the molecular weight of the protein is small and there are two disulfide bonds in the molecule, it is difficult to express the protein in Escherichia ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/405C12N15/31C12N15/63C12N1/21C07K17/08A61K38/16A61K47/48A61P31/18C12R1/89C12R1/19
CPCA61K47/48215A61K38/00C07K14/195A61K47/60A61P31/18
Inventor 熊盛陈伟钱垂文王一飞北里海雄
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products